Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
237 hedge funds and large institutions have $3.04B invested in Cantel Medical Corporation in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 89 increasing their positions, 70 reducing their positions, and 31 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
27% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 70
2% more capital invested
Capital invested by funds: $2.99B → $3.04B (+$46.9M)
1% more call options, than puts
Call options by funds: $7.2M | Put options by funds: $7.1M
3% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 31
3% less funds holding
Funds holding: 244 → 237 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$71.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$43.4M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$18.3M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$16.8M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$14.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$18.9M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$10.1M |
| 3 |
BAMCO Inc
New York
|
-$7.25M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$7.23M |
| 5 |
Millennium Management
New York
|
-$7.02M |
CMD Hedge Fund Activity: Q4 2019 in Review
237 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2019, worth a combined $3.04B — up 1.6% from $2.99B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of CMD and 30 opened new positions — a net loss of 1 holder — while 70 trimmed existing stakes and 89 added.
The largest buyer was Champlain Investment Partners, adding an estimated $71.4M. The largest seller was Select Equity Group, cutting an estimated $18.9M.
- 237 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2019, down from 244 in Q3 2019.
- Funds reported $3.04B of Cantel Medical Corporation stock for Q4 2019, up 1.6% quarter-over-quarter.
- 30 funds opened new Cantel Medical Corporation positions in Q4 2019 and 31 closed out, a net change of -1 holder.
- The largest Cantel Medical Corporation buyer in Q4 2019 was Champlain Investment Partners, an estimated $71.4M added.
- The largest Cantel Medical Corporation seller in Q4 2019 was Select Equity Group, an estimated $18.9M sold.
Based on aggregated 13F filings for Q4 2019.